nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—Etoposide—muscle cancer	0.074	0.449	CbGbCtD
Eszopiclone—CYP2C8—Etoposide—muscle cancer	0.0427	0.259	CbGbCtD
Eszopiclone—CYP3A4—Vincristine—muscle cancer	0.0189	0.115	CbGbCtD
Eszopiclone—TSPO—hindlimb—muscle cancer	0.0175	0.133	CbGeAlD
Eszopiclone—CYP3A4—Etoposide—muscle cancer	0.0173	0.105	CbGbCtD
Eszopiclone—TSPO—appendage—muscle cancer	0.015	0.114	CbGeAlD
Eszopiclone—CYP3A4—Doxorubicin—muscle cancer	0.0118	0.0717	CbGbCtD
Eszopiclone—GABRG3—head—muscle cancer	0.00511	0.0388	CbGeAlD
Eszopiclone—TSPO—embryo—muscle cancer	0.00498	0.0378	CbGeAlD
Eszopiclone—GABRG3—testis—muscle cancer	0.00493	0.0375	CbGeAlD
Eszopiclone—GABRA4—tendon—muscle cancer	0.00416	0.0316	CbGeAlD
Eszopiclone—GABRA5—head—muscle cancer	0.00393	0.0298	CbGeAlD
Eszopiclone—TSPO—smooth muscle tissue—muscle cancer	0.00391	0.0297	CbGeAlD
Eszopiclone—GABRA5—testis—muscle cancer	0.00379	0.0288	CbGeAlD
Eszopiclone—TSPO—renal system—muscle cancer	0.00377	0.0286	CbGeAlD
Eszopiclone—GABRA3—head—muscle cancer	0.00365	0.0278	CbGeAlD
Eszopiclone—GABRA4—head—muscle cancer	0.00356	0.027	CbGeAlD
Eszopiclone—GABRA3—testis—muscle cancer	0.00353	0.0268	CbGeAlD
Eszopiclone—TSPO—cardiac atrium—muscle cancer	0.00337	0.0256	CbGeAlD
Eszopiclone—GABRG2—head—muscle cancer	0.00298	0.0226	CbGeAlD
Eszopiclone—GABRB2—head—muscle cancer	0.00298	0.0226	CbGeAlD
Eszopiclone—GABRA2—vagina—muscle cancer	0.00295	0.0224	CbGeAlD
Eszopiclone—TSPO—tendon—muscle cancer	0.00294	0.0223	CbGeAlD
Eszopiclone—GABRB2—testis—muscle cancer	0.00288	0.0219	CbGeAlD
Eszopiclone—TSPO—bone marrow—muscle cancer	0.00285	0.0216	CbGeAlD
Eszopiclone—TSPO—vagina—muscle cancer	0.00273	0.0207	CbGeAlD
Eszopiclone—GABRA2—head—muscle cancer	0.00272	0.0207	CbGeAlD
Eszopiclone—GABRA1—head—muscle cancer	0.00263	0.02	CbGeAlD
Eszopiclone—CYP2C8—renal system—muscle cancer	0.00258	0.0196	CbGeAlD
Eszopiclone—TSPO—head—muscle cancer	0.00252	0.0191	CbGeAlD
Eszopiclone—TSPO—testis—muscle cancer	0.00243	0.0185	CbGeAlD
Eszopiclone—PTGS1—smooth muscle tissue—muscle cancer	0.00218	0.0165	CbGeAlD
Eszopiclone—PTGS1—renal system—muscle cancer	0.0021	0.0159	CbGeAlD
Eszopiclone—PTGS1—cardiac atrium—muscle cancer	0.00188	0.0143	CbGeAlD
Eszopiclone—CYP2C8—vagina—muscle cancer	0.00187	0.0142	CbGeAlD
Eszopiclone—Dry eye—Doxorubicin—muscle cancer	0.0018	0.00255	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00179	0.00254	CcSEcCtD
Eszopiclone—Erythema multiforme—Etoposide—muscle cancer	0.00178	0.00253	CcSEcCtD
Eszopiclone—Rash maculo-papular—Doxorubicin—muscle cancer	0.00177	0.00251	CcSEcCtD
Eszopiclone—Anorexia—Dactinomycin—muscle cancer	0.00176	0.0025	CcSEcCtD
Eszopiclone—Bladder pain—Doxorubicin—muscle cancer	0.00176	0.0025	CcSEcCtD
Eszopiclone—Mouth ulceration—Doxorubicin—muscle cancer	0.00176	0.0025	CcSEcCtD
Eszopiclone—Convulsion—Vincristine—muscle cancer	0.00175	0.00249	CcSEcCtD
Eszopiclone—CYP3A4—renal system—muscle cancer	0.00175	0.0133	CbGeAlD
Eszopiclone—Hypertension—Vincristine—muscle cancer	0.00175	0.00248	CcSEcCtD
Eszopiclone—Myalgia—Vincristine—muscle cancer	0.00172	0.00245	CcSEcCtD
Eszopiclone—Hypertonia—Doxorubicin—muscle cancer	0.0017	0.00242	CcSEcCtD
Eszopiclone—Chills—Etoposide—muscle cancer	0.00169	0.0024	CcSEcCtD
Eszopiclone—Mental disability—Doxorubicin—muscle cancer	0.00169	0.0024	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00168	0.00239	CcSEcCtD
Eszopiclone—CYP2C8—testis—muscle cancer	0.00167	0.0127	CbGeAlD
Eszopiclone—Alopecia—Etoposide—muscle cancer	0.00166	0.00236	CcSEcCtD
Eszopiclone—Lymphadenopathy—Doxorubicin—muscle cancer	0.00165	0.00235	CcSEcCtD
Eszopiclone—Anaphylactic shock—Vincristine—muscle cancer	0.00165	0.00235	CcSEcCtD
Eszopiclone—Infection—Vincristine—muscle cancer	0.00164	0.00233	CcSEcCtD
Eszopiclone—PTGS1—tendon—muscle cancer	0.00164	0.0124	CbGeAlD
Eszopiclone—Thrombophlebitis—Doxorubicin—muscle cancer	0.00163	0.00232	CcSEcCtD
Eszopiclone—Osteoarthritis—Methotrexate—muscle cancer	0.00163	0.00232	CcSEcCtD
Eszopiclone—Photosensitivity—Doxorubicin—muscle cancer	0.00161	0.00228	CcSEcCtD
Eszopiclone—Decreased appetite—Dactinomycin—muscle cancer	0.00161	0.00228	CcSEcCtD
Eszopiclone—Dysgeusia—Etoposide—muscle cancer	0.0016	0.00228	CcSEcCtD
Eszopiclone—Hyperhidrosis—Vincristine—muscle cancer	0.0016	0.00227	CcSEcCtD
Eszopiclone—Fatigue—Dactinomycin—muscle cancer	0.00159	0.00226	CcSEcCtD
Eszopiclone—Back pain—Etoposide—muscle cancer	0.00159	0.00225	CcSEcCtD
Eszopiclone—Pain—Dactinomycin—muscle cancer	0.00158	0.00225	CcSEcCtD
Eszopiclone—Muscle spasms—Etoposide—muscle cancer	0.00158	0.00224	CcSEcCtD
Eszopiclone—Anorexia—Vincristine—muscle cancer	0.00157	0.00224	CcSEcCtD
Eszopiclone—Eczema—Doxorubicin—muscle cancer	0.00157	0.00223	CcSEcCtD
Eszopiclone—Irritability—Methotrexate—muscle cancer	0.00156	0.00221	CcSEcCtD
Eszopiclone—Mood swings—Methotrexate—muscle cancer	0.00154	0.00219	CcSEcCtD
Eszopiclone—Ataxia—Methotrexate—muscle cancer	0.00153	0.00218	CcSEcCtD
Eszopiclone—Feeling abnormal—Dactinomycin—muscle cancer	0.00152	0.00216	CcSEcCtD
Eszopiclone—Ill-defined disorder—Etoposide—muscle cancer	0.00152	0.00216	CcSEcCtD
Eszopiclone—PTGS1—vagina—muscle cancer	0.00152	0.0115	CbGeAlD
Eszopiclone—Anaemia—Etoposide—muscle cancer	0.00151	0.00215	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00151	0.00215	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0015	0.00214	CcSEcCtD
Eszopiclone—Increased appetite—Doxorubicin—muscle cancer	0.0015	0.00213	CcSEcCtD
Eszopiclone—Insomnia—Vincristine—muscle cancer	0.00149	0.00212	CcSEcCtD
Eszopiclone—Paraesthesia—Vincristine—muscle cancer	0.00148	0.00211	CcSEcCtD
Eszopiclone—Malaise—Etoposide—muscle cancer	0.00148	0.0021	CcSEcCtD
Eszopiclone—Dermatitis bullous—Doxorubicin—muscle cancer	0.00148	0.0021	CcSEcCtD
Eszopiclone—Vertigo—Etoposide—muscle cancer	0.00147	0.00209	CcSEcCtD
Eszopiclone—Body temperature increased—Dactinomycin—muscle cancer	0.00146	0.00208	CcSEcCtD
Eszopiclone—Abdominal pain—Dactinomycin—muscle cancer	0.00146	0.00208	CcSEcCtD
Eszopiclone—Decreased appetite—Vincristine—muscle cancer	0.00144	0.00204	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Vincristine—muscle cancer	0.00143	0.00203	CcSEcCtD
Eszopiclone—Fatigue—Vincristine—muscle cancer	0.00142	0.00202	CcSEcCtD
Eszopiclone—Convulsion—Etoposide—muscle cancer	0.00142	0.00202	CcSEcCtD
Eszopiclone—Hypertension—Etoposide—muscle cancer	0.00141	0.00201	CcSEcCtD
Eszopiclone—Pain—Vincristine—muscle cancer	0.00141	0.00201	CcSEcCtD
Eszopiclone—Constipation—Vincristine—muscle cancer	0.00141	0.00201	CcSEcCtD
Eszopiclone—Osteoarthritis—Doxorubicin—muscle cancer	0.00141	0.00201	CcSEcCtD
Eszopiclone—Diplopia—Doxorubicin—muscle cancer	0.00141	0.00201	CcSEcCtD
Eszopiclone—Asthma—Methotrexate—muscle cancer	0.00141	0.002	CcSEcCtD
Eszopiclone—PTGS1—head—muscle cancer	0.0014	0.0106	CbGeAlD
Eszopiclone—Chest pain—Etoposide—muscle cancer	0.0014	0.00198	CcSEcCtD
Eszopiclone—Affect lability—Doxorubicin—muscle cancer	0.00139	0.00197	CcSEcCtD
Eszopiclone—Migraine—Doxorubicin—muscle cancer	0.00139	0.00197	CcSEcCtD
Eszopiclone—Discomfort—Etoposide—muscle cancer	0.00138	0.00196	CcSEcCtD
Eszopiclone—Face oedema—Doxorubicin—muscle cancer	0.00136	0.00194	CcSEcCtD
Eszopiclone—Hypersensitivity—Dactinomycin—muscle cancer	0.00136	0.00193	CcSEcCtD
Eszopiclone—PTGS1—testis—muscle cancer	0.00135	0.0103	CbGeAlD
Eszopiclone—Gastrointestinal pain—Vincristine—muscle cancer	0.00135	0.00192	CcSEcCtD
Eszopiclone—Confusional state—Etoposide—muscle cancer	0.00135	0.00192	CcSEcCtD
Eszopiclone—Anaphylactic shock—Etoposide—muscle cancer	0.00134	0.0019	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—muscle cancer	0.00134	0.0019	CcSEcCtD
Eszopiclone—Infection—Etoposide—muscle cancer	0.00133	0.00189	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—muscle cancer	0.00133	0.00189	CcSEcCtD
Eszopiclone—Asthenia—Dactinomycin—muscle cancer	0.00133	0.00188	CcSEcCtD
Eszopiclone—Dysuria—Methotrexate—muscle cancer	0.00132	0.00187	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—muscle cancer	0.00131	0.00187	CcSEcCtD
Eszopiclone—Tachycardia—Etoposide—muscle cancer	0.00131	0.00186	CcSEcCtD
Eszopiclone—Abdominal pain—Vincristine—muscle cancer	0.00131	0.00185	CcSEcCtD
Eszopiclone—Body temperature increased—Vincristine—muscle cancer	0.00131	0.00185	CcSEcCtD
Eszopiclone—Erectile dysfunction—Methotrexate—muscle cancer	0.0013	0.00184	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—muscle cancer	0.00129	0.00184	CcSEcCtD
Eszopiclone—Hyperhidrosis—Etoposide—muscle cancer	0.00129	0.00184	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Methotrexate—muscle cancer	0.00129	0.00183	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—muscle cancer	0.00128	0.00183	CcSEcCtD
Eszopiclone—Anorexia—Etoposide—muscle cancer	0.00127	0.00181	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00127	0.00181	CcSEcCtD
Eszopiclone—Diarrhoea—Dactinomycin—muscle cancer	0.00126	0.0018	CcSEcCtD
Eszopiclone—Drowsiness—Methotrexate—muscle cancer	0.00126	0.00179	CcSEcCtD
Eszopiclone—Depression—Methotrexate—muscle cancer	0.00125	0.00178	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—muscle cancer	0.00125	0.00178	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—muscle cancer	0.00124	0.00177	CcSEcCtD
Eszopiclone—Stomatitis—Methotrexate—muscle cancer	0.00122	0.00174	CcSEcCtD
Eszopiclone—Conjunctivitis—Methotrexate—muscle cancer	0.00122	0.00174	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—muscle cancer	0.00122	0.00173	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—muscle cancer	0.00122	0.00173	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—muscle cancer	0.00122	0.00173	CcSEcCtD
Eszopiclone—Hypersensitivity—Vincristine—muscle cancer	0.00122	0.00173	CcSEcCtD
Eszopiclone—Sweating—Methotrexate—muscle cancer	0.0012	0.00171	CcSEcCtD
Eszopiclone—Paraesthesia—Etoposide—muscle cancer	0.0012	0.00171	CcSEcCtD
Eszopiclone—Haematuria—Methotrexate—muscle cancer	0.0012	0.0017	CcSEcCtD
Eszopiclone—Dyspnoea—Etoposide—muscle cancer	0.00119	0.00169	CcSEcCtD
Eszopiclone—Somnolence—Etoposide—muscle cancer	0.00119	0.00169	CcSEcCtD
Eszopiclone—Epistaxis—Methotrexate—muscle cancer	0.00118	0.00168	CcSEcCtD
Eszopiclone—Asthenia—Vincristine—muscle cancer	0.00118	0.00168	CcSEcCtD
Eszopiclone—Vomiting—Dactinomycin—muscle cancer	0.00117	0.00167	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—muscle cancer	0.00117	0.00167	CcSEcCtD
Eszopiclone—Rash—Dactinomycin—muscle cancer	0.00117	0.00166	CcSEcCtD
Eszopiclone—Decreased appetite—Etoposide—muscle cancer	0.00116	0.00165	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Etoposide—muscle cancer	0.00115	0.00164	CcSEcCtD
Eszopiclone—Fatigue—Etoposide—muscle cancer	0.00115	0.00164	CcSEcCtD
Eszopiclone—Constipation—Etoposide—muscle cancer	0.00114	0.00163	CcSEcCtD
Eszopiclone—Pain—Etoposide—muscle cancer	0.00114	0.00163	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—muscle cancer	0.00114	0.00162	CcSEcCtD
Eszopiclone—Diarrhoea—Vincristine—muscle cancer	0.00113	0.00161	CcSEcCtD
Eszopiclone—Hepatitis—Methotrexate—muscle cancer	0.00113	0.0016	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—muscle cancer	0.00113	0.0016	CcSEcCtD
Eszopiclone—Pharyngitis—Methotrexate—muscle cancer	0.00112	0.00159	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00111	0.00158	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—muscle cancer	0.00111	0.00158	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—muscle cancer	0.0011	0.00157	CcSEcCtD
Eszopiclone—Feeling abnormal—Etoposide—muscle cancer	0.0011	0.00157	CcSEcCtD
Eszopiclone—Nausea—Dactinomycin—muscle cancer	0.0011	0.00156	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Etoposide—muscle cancer	0.00109	0.00155	CcSEcCtD
Eszopiclone—Dizziness—Vincristine—muscle cancer	0.00109	0.00155	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—muscle cancer	0.00109	0.00155	CcSEcCtD
Eszopiclone—Erythema multiforme—Methotrexate—muscle cancer	0.00107	0.00152	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00107	0.00152	CcSEcCtD
Eszopiclone—Urticaria—Etoposide—muscle cancer	0.00106	0.00151	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—muscle cancer	0.00106	0.00151	CcSEcCtD
Eszopiclone—Body temperature increased—Etoposide—muscle cancer	0.00106	0.0015	CcSEcCtD
Eszopiclone—Abdominal pain—Etoposide—muscle cancer	0.00106	0.0015	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—muscle cancer	0.00106	0.0015	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—muscle cancer	0.00106	0.0015	CcSEcCtD
Eszopiclone—Tinnitus—Methotrexate—muscle cancer	0.00105	0.00149	CcSEcCtD
Eszopiclone—Vomiting—Vincristine—muscle cancer	0.00105	0.00149	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—muscle cancer	0.00104	0.00148	CcSEcCtD
Eszopiclone—Rash—Vincristine—muscle cancer	0.00104	0.00148	CcSEcCtD
Eszopiclone—Dermatitis—Vincristine—muscle cancer	0.00104	0.00148	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—muscle cancer	0.00104	0.00147	CcSEcCtD
Eszopiclone—Headache—Vincristine—muscle cancer	0.00103	0.00147	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—muscle cancer	0.00103	0.00146	CcSEcCtD
Eszopiclone—Chills—Methotrexate—muscle cancer	0.00101	0.00144	CcSEcCtD
Eszopiclone—Alopecia—Methotrexate—muscle cancer	0.000996	0.00142	CcSEcCtD
Eszopiclone—Hypersensitivity—Etoposide—muscle cancer	0.000985	0.0014	CcSEcCtD
Eszopiclone—Nausea—Vincristine—muscle cancer	0.000981	0.00139	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—muscle cancer	0.000979	0.00139	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—muscle cancer	0.000976	0.00139	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000972	0.00138	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—muscle cancer	0.000969	0.00138	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—muscle cancer	0.000962	0.00137	CcSEcCtD
Eszopiclone—Dysgeusia—Methotrexate—muscle cancer	0.000961	0.00137	CcSEcCtD
Eszopiclone—Asthenia—Etoposide—muscle cancer	0.00096	0.00136	CcSEcCtD
Eszopiclone—Back pain—Methotrexate—muscle cancer	0.00095	0.00135	CcSEcCtD
Eszopiclone—Pruritus—Etoposide—muscle cancer	0.000946	0.00134	CcSEcCtD
Eszopiclone—Vision blurred—Methotrexate—muscle cancer	0.000925	0.00131	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—muscle cancer	0.000923	0.00131	CcSEcCtD
Eszopiclone—Diarrhoea—Etoposide—muscle cancer	0.000915	0.0013	CcSEcCtD
Eszopiclone—Ill-defined disorder—Methotrexate—muscle cancer	0.000911	0.00129	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—muscle cancer	0.00091	0.00129	CcSEcCtD
Eszopiclone—Anaemia—Methotrexate—muscle cancer	0.000907	0.00129	CcSEcCtD
Eszopiclone—Malaise—Methotrexate—muscle cancer	0.000885	0.00126	CcSEcCtD
Eszopiclone—Dizziness—Etoposide—muscle cancer	0.000884	0.00126	CcSEcCtD
Eszopiclone—Vertigo—Methotrexate—muscle cancer	0.000882	0.00125	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—muscle cancer	0.000876	0.00125	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—muscle cancer	0.000863	0.00123	CcSEcCtD
Eszopiclone—Convulsion—Methotrexate—muscle cancer	0.000851	0.00121	CcSEcCtD
Eszopiclone—Vomiting—Etoposide—muscle cancer	0.00085	0.00121	CcSEcCtD
Eszopiclone—Rash—Etoposide—muscle cancer	0.000843	0.0012	CcSEcCtD
Eszopiclone—Dermatitis—Etoposide—muscle cancer	0.000843	0.0012	CcSEcCtD
Eszopiclone—Headache—Etoposide—muscle cancer	0.000838	0.00119	CcSEcCtD
Eszopiclone—Chest pain—Methotrexate—muscle cancer	0.000836	0.00119	CcSEcCtD
Eszopiclone—Myalgia—Methotrexate—muscle cancer	0.000836	0.00119	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—muscle cancer	0.000834	0.00119	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—muscle cancer	0.000832	0.00118	CcSEcCtD
Eszopiclone—Discomfort—Methotrexate—muscle cancer	0.000826	0.00117	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—muscle cancer	0.000826	0.00117	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—muscle cancer	0.000822	0.00117	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—muscle cancer	0.000817	0.00116	CcSEcCtD
Eszopiclone—Confusional state—Methotrexate—muscle cancer	0.000808	0.00115	CcSEcCtD
Eszopiclone—Anaphylactic shock—Methotrexate—muscle cancer	0.000801	0.00114	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—muscle cancer	0.000801	0.00114	CcSEcCtD
Eszopiclone—Infection—Methotrexate—muscle cancer	0.000796	0.00113	CcSEcCtD
Eszopiclone—Nausea—Etoposide—muscle cancer	0.000794	0.00113	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000789	0.00112	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—muscle cancer	0.000786	0.00112	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—muscle cancer	0.000781	0.00111	CcSEcCtD
Eszopiclone—Hyperhidrosis—Methotrexate—muscle cancer	0.000774	0.0011	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—muscle cancer	0.000767	0.00109	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—muscle cancer	0.000764	0.00109	CcSEcCtD
Eszopiclone—Anorexia—Methotrexate—muscle cancer	0.000764	0.00109	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—muscle cancer	0.000751	0.00107	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—muscle cancer	0.000736	0.00105	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—muscle cancer	0.000734	0.00104	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00073	0.00104	CcSEcCtD
Eszopiclone—Insomnia—Methotrexate—muscle cancer	0.000725	0.00103	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—muscle cancer	0.000724	0.00103	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—muscle cancer	0.000724	0.00103	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—muscle cancer	0.000721	0.00102	CcSEcCtD
Eszopiclone—Paraesthesia—Methotrexate—muscle cancer	0.000719	0.00102	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—muscle cancer	0.000715	0.00102	CcSEcCtD
Eszopiclone—Dyspnoea—Methotrexate—muscle cancer	0.000714	0.00102	CcSEcCtD
Eszopiclone—Somnolence—Methotrexate—muscle cancer	0.000712	0.00101	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—muscle cancer	0.000708	0.00101	CcSEcCtD
Eszopiclone—Dyspepsia—Methotrexate—muscle cancer	0.000705	0.001	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—muscle cancer	0.000699	0.000994	CcSEcCtD
Eszopiclone—Decreased appetite—Methotrexate—muscle cancer	0.000696	0.00099	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000694	0.000986	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000692	0.000983	CcSEcCtD
Eszopiclone—Fatigue—Methotrexate—muscle cancer	0.000691	0.000982	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—muscle cancer	0.000689	0.000979	CcSEcCtD
Eszopiclone—Pain—Methotrexate—muscle cancer	0.000685	0.000974	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—muscle cancer	0.000677	0.000962	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000671	0.000953	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—muscle cancer	0.000661	0.00094	CcSEcCtD
Eszopiclone—Feeling abnormal—Methotrexate—muscle cancer	0.00066	0.000938	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000655	0.000931	CcSEcCtD
Eszopiclone—Urticaria—Methotrexate—muscle cancer	0.000636	0.000904	CcSEcCtD
Eszopiclone—Body temperature increased—Methotrexate—muscle cancer	0.000633	0.0009	CcSEcCtD
Eszopiclone—Abdominal pain—Methotrexate—muscle cancer	0.000633	0.0009	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000632	0.000898	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—muscle cancer	0.000627	0.000892	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—muscle cancer	0.000623	0.000885	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—muscle cancer	0.000618	0.000879	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—muscle cancer	0.000617	0.000876	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—muscle cancer	0.000611	0.000868	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—muscle cancer	0.000603	0.000857	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000599	0.000851	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—muscle cancer	0.000598	0.00085	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—muscle cancer	0.000593	0.000843	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—muscle cancer	0.000593	0.000843	CcSEcCtD
Eszopiclone—Hypersensitivity—Methotrexate—muscle cancer	0.00059	0.000839	CcSEcCtD
Eszopiclone—Asthenia—Methotrexate—muscle cancer	0.000575	0.000817	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—muscle cancer	0.000572	0.000812	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000567	0.000806	CcSEcCtD
Eszopiclone—Pruritus—Methotrexate—muscle cancer	0.000567	0.000805	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—muscle cancer	0.000551	0.000783	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—muscle cancer	0.000548	0.000779	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—muscle cancer	0.000548	0.000779	CcSEcCtD
Eszopiclone—Diarrhoea—Methotrexate—muscle cancer	0.000548	0.000779	CcSEcCtD
Eszopiclone—Dizziness—Methotrexate—muscle cancer	0.00053	0.000753	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—muscle cancer	0.000511	0.000726	CcSEcCtD
Eszopiclone—Vomiting—Methotrexate—muscle cancer	0.000509	0.000724	CcSEcCtD
Eszopiclone—Rash—Methotrexate—muscle cancer	0.000505	0.000718	CcSEcCtD
Eszopiclone—Dermatitis—Methotrexate—muscle cancer	0.000505	0.000717	CcSEcCtD
Eszopiclone—Headache—Methotrexate—muscle cancer	0.000502	0.000713	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—muscle cancer	0.000498	0.000707	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—muscle cancer	0.000491	0.000697	CcSEcCtD
Eszopiclone—Nausea—Methotrexate—muscle cancer	0.000476	0.000676	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—muscle cancer	0.000475	0.000675	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—muscle cancer	0.000459	0.000652	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—muscle cancer	0.000441	0.000627	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—muscle cancer	0.000437	0.000622	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—muscle cancer	0.000437	0.000621	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—muscle cancer	0.000435	0.000618	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—muscle cancer	0.000412	0.000586	CcSEcCtD
